Department of Pain Management, BG University Hospital Bergmannsheil GmbH, Ruhr University Bochum, Bochum, Germany.
Pain. 2012 Feb;153(2):273-280. doi: 10.1016/j.pain.2011.08.020. Epub 2011 Oct 11.
Topical lidocaine (5%) leads to sufficient pain relief in only 29%-80% of treated patients, presumably by small-fiber block. The reasons for nonresponse are unclear; it may be due to different underlying pain mechanisms or partly insufficient anesthetic effect. Using quantitative sensory testing (QST) following the protocol of the DFNS (German Research Network on Neuropathic Pain), this study aims to assess the type and extent of somatosensory changes after lidocaine application in healthy volunteers. Twenty-six healthy volunteers underwent QST on the volar forearm, including thermal and mechanical detection and pain thresholds, twice before (for baseline retest reliability) and once after 6-hour simultaneous application with lidocaine patch 5% and contralateral placebo in a double-blinded manner. Pre and post differences of QST parameters were analyzed by paired t-test (Bonferroni-corrected alpha 0.0023). QST profiles did not change between the 2 baseline measurements and after the placebo application. Lidocaine application led to a significant change of only the small-fiber-associated thresholds (increase of thermal detection and mechanical pain thresholds, decrease of mechanical pain sensitivity). Tactile detection thresholds representing Aβ function remained unchanged. Interindividually, the extent of the small-fiber block varied widely (eg, thermal detection thresholds: in 54% of the subjects there were only minimal changes; in only 8% were there changes of >60% of the maximal achievable value). Topical lidocaine (5%) induces thermal hypoesthesia and pinprick hypoalgesia, suggesting an isolated but only partial block of Aδ and C fibers of unpredictable extent. Further studies must analyze the influencing factors and determine whether patients with poor analgesic effect, in particular, are those with insufficient small-fiber block.
局部利多卡因(5%)仅能使 29%-80%的治疗患者获得充分的疼痛缓解,这可能是通过小纤维阻滞实现的。其无反应的原因尚不清楚;可能是由于不同的潜在疼痛机制,也可能部分是由于麻醉效果不足。本研究采用德国神经病学学会(DFNS)制定的方案进行定量感觉测试(QST),旨在评估利多卡因应用于健康志愿者后感觉变化的类型和程度。26 名健康志愿者在前臂掌侧接受 QST,包括热觉和机械觉检测以及痛觉阈值,在两次(用于基础测试重测可靠性)和一次(在 6 小时内同时使用利多卡因贴剂 5%和对侧安慰剂的情况下,以双盲方式)之后进行。通过配对 t 检验(经 Bonferroni 校正的α=0.0023)分析 QST 参数的预-后差异。QST 特征在两次基线测量之间和安慰剂应用后没有变化。利多卡因的应用仅导致与小纤维相关的阈值发生显著变化(热觉检测阈值和机械痛阈值增加,机械痛敏阈值降低)。代表 Aβ功能的触觉检测阈值保持不变。个体间小纤维阻滞的程度差异很大(例如,热觉检测阈值:在 54%的受试者中仅出现最小的变化;在仅 8%的受试者中,变化超过了最大可实现值的 60%)。局部利多卡因(5%)可引起热觉迟钝和刺痛觉减退,表明 Aδ和 C 纤维的孤立但不完全阻滞,其程度不可预测。进一步的研究必须分析影响因素,并确定是否镇痛效果不佳的患者,特别是那些小纤维阻滞不足的患者。